홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Chlorotrimethylsilane → (S)-3-{3-Benzyloxy-4-[1,1,4-trioxo-5-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-2-yl]-phenyl}-2-tert-butoxycarbonylaminopropionic Acid Tert-butyl Ester

HRID 660634
인쇄

반응식

HRID 660634 반응식
Cl[Si](C)(C)C.[C:6]([O:10][C:11](=[O:23])[C@@H:12]([NH:15][C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:13]I)([CH3:9])([CH3:8])[CH3:7].[CH2:24]([O:31][C:32]1[CH:37]=[C:36](I)[CH:35]=[CH:34][C:33]=1[N:39]1[S:43](=[O:45])(=[O:44])[N:42]([CH2:46][CH2:47][Si:48]([CH3:51])([CH3:50])[CH3:49])[C:41](=[O:52])[CH2:40]1)[C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.C1(C)C=CC=CC=1P(C1C=CC=CC=1C)C1C=CC=CC=1C>CN(C=O)C.[Zn].C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].O>[C:6]([O:10][C:11](=[O:23])[C@@H:12]([NH:15][C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:13][C:36]1[CH:35]=[CH:34][C:33]([N:39]2[CH2:40][C:41](=[O:52])[N:42]([CH2:46][CH2:47][Si:48]([CH3:51])([CH3:50])[CH3:49])[S:43]2(=[O:45])=[O:44])=[C:32]([O:31][CH2:24][C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=2)[CH:37]=1)([CH3:9])([CH3:8])[CH3:7]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 4

HCID 6397ChlorotrimethylsilaneHCID 80271Tri-o-tolylphosphineHCID 54762716(R)-2-tert-butoxycarbonylamino-3-iodopropionic acid tert-butyl esterHCID 667569375-(2-Benzyloxy-4-iodophenyl)-1,1-dioxo-2-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-3-one

생성물 1

HCID 68840018
(S)-3-{3-Benzyloxy-4-[1,1,4-trioxo-5-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-2-yl]-phenyl}-2-tert-butoxycarbonylaminopropionic Acid Tert-butyl Ester

시약·촉매·용매 4

HCID 23994Zinc촉매HCID 9811564Bis(dibenzylideneacetone)palladium촉매HCID 962Water용매HCID 6228Dimethylformamide용매3회

실험 절차

To a suspension of zinc powder (645 mg, 9.9 mmol) in DMF (1 mL) under argon is added chlorotrimethylsilane (83 mg, 0.76 mmol) and the mixture is stirred at RT for 30 min. To this is added a solution of (R)-2-tert-butoxycarbonylamino-3-iodopropionic acid tert-butyl ester (1.1 g, 2.96 mmol) in DMF (1.8 mL) dropwise and the mixture is stirred at RT for 30 min. An additional 2.5 mL of DMF is added and any insoluble material is filtered. The filtrate is added to a mixture of 5-(2-benzyloxy-4-iodophenyl)-1,1-dioxo-2-(2-trimethylsilanylethyl)-1,2,5-thiadiazolidin-3-one (900 mg, 1.65 mmol), tri-o-tolylphosphine (100 mg, 0.33 mmol) and Pd2(dba)3 (74 mg, 0.08 mmol) and the mixture is stirred at RT for 90 min. Water is added and the mixture is extracted with EtOAc. The organic phase is washed with water (2×) and brine then is dried over sodium sulfate. The solvent is remover under reduced pressure and the residue is purified by flash chromatography using EtOAc/hexane (10%) as eluent to give the title compound as an off-white solid.

후처리

  1. stirringthe mixture is stirred at RT for 30 min
  2. filtrationany insoluble material is filtered
  3. stirringthe mixture is stirred at RT for 90 min
  4. extractionthe mixture is extracted with EtOAc
  5. washThe organic phase is washed with water (2×) and brine
  6. dry with materialthen is dried over sodium sulfate
  7. customthe residue is purified by flash chromatography

출처 및 근거

ORD 기록
ord-05dd9d8117dc4be4a8c02d3792c3dffd
출처 데이터셋
uspto-grants-2011_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08084448B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트